TriPath Imaging, Inc. Announces Promotions of Johnny D. Powers, Ph.D. to President, TriPath Oncology and James D. Petrilla to S
July 19 2006 - 8:37AM
PR Newswire (US)
BURLINGTON, N.C., July 19 /PRNewswire-FirstCall/ -- TriPath
Imaging, Inc. (NASDAQ:TPTH), announced today that Johnny D. Powers,
Ph.D., the Company's Senior Vice President and General Manager,
TriPath Oncology has been promoted to President, TriPath Oncology
and that James D. Petrilla, the Company's Vice President, Worldwide
Marketing and Customer Training, has been promoted to Senior Vice
President, Commercial Operations. Ray W. Swanson has resigned his
position as Senior Vice President, Commercial Operations and will
leave the Company to pursue other interests. "I would like to
congratulate Johnny Powers and Jim Petrilla on their well-deserved
promotions, and I look forward to working with them in their
expanded roles," said Paul R. Sohmer, M.D., Chairman, President and
CEO of TriPath Imaging, Inc. "I would also like to thank Ray
Swanson for his many contributions since joining the Company in
2001." Dr. Powers will continue to lead the TriPath Oncology
business unit and will also assume leadership of the Company's
manufacturing and quality assurance functions. He joined TriPath
Imaging in October 2001 upon appointment as Vice President of
Manufacturing Operations. In July 2002, he was promoted to Senior
Vice President and General Manager, TriPath Oncology, the Company's
wholly-owned subsidiary that is developing molecular diagnostic
products for cancers of the cervix, breast, ovary and prostate.
Prior to joining TriPath Imaging, Dr. Powers served as Vice
President and General Manager of Manufacturing Operations, Vice
President and General Manager of Worldwide Strategic Marketing, and
Vice President of Molecular Diagnostic Systems Business Unit at
Ventana Medical Systems, Inc. In his new role, Mr. Petrilla will
assume leadership of the Company's cervical cancer screening
business. Mr. Petrilla joined the Company in January 2006 as Vice
President, Worldwide Marketing and Customer Training. Prior to
joining TriPath Imaging, Mr. Petrilla served as President and CEO
of StemCo Biomedical, Inc., Vice President and General Manager of
the Biovail Corporation, and Vice President, Global Brand Champion
(Chairman of Full Development Team), General Manager (VP)
Anti-Virals Europe, Vice President, National Accounts, and Vice
President, Managed Care Sales-East Area at the Bristol-Meyers
Squibb Company. Mr. Petrilla is a graduate of the United States
Naval Academy. TriPath Imaging, Inc., headquartered in Burlington,
North Carolina, develops, manufactures, markets and sells
innovative solutions to improve the clinical management of cancer,
including detection, diagnosis, staging and treatment. TriPath
Oncology, a wholly-owned subsidiary of TriPath Imaging, develops
molecular diagnostic products for malignant melanoma and cancers of
the cervix, breast, ovary and prostate. For more information on
TriPath Imaging please visit our web site at
http://www.tripathimaging.com/. DATASOURCE: TriPath Imaging, Inc.
CONTACT: Stephen P. Hall, Chief Financial Officer of TriPath
Imaging, Inc., +1-336-290-8721 Web site:
http://www.tripathimaging.com/
Copyright
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Sep 2023 to Sep 2024